{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:46:53Z","timestamp":1791539213149,"version":"4.3.4"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/dsu.12057","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T17:52:40Z","timestamp":1355853160000},"page":"24-29","source":"Crossref","is-referenced-by-count":21,"title":["Facial Blanching Due to Neurotoxins: Proposed Mechanisms"],"prefix":"10.1097","volume":"39","author":[{"given":"Tanya T.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Herne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-2-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1353\/pbm.1997.0032","article-title":"Botulinum toxin: the story of its development for the treatment of human disease.","volume":"40","author":"Schantz","year":"1997","journal-title":"Perspect Biol Med"},{"issue":"5","key":"R2-2-20210206","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.toxicon.2009.02.003","article-title":"Discussion of unique properties of botulinum toxins.","volume":"54","author":"Albanese","year":"2009","journal-title":"Toxicon"},{"key":"R3-2-20210206","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20010","article-title":"Different types of botulinum toxin in human.","volume":"19","author":"Eleopra","year":"2004","journal-title":"Mov Disord"},{"issue":"suppl","key":"R4-2-20210206","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1002\/mds.20066","article-title":"Clinical comparability of marketed formulations of botulinum toxin.","volume":"19","author":"Sampaio","year":"2004","journal-title":"Mov Disord"},{"issue":"7","key":"R5-2-20210206","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM200102153440704","article-title":"Botulinum toxin A for axillary hyperhidrosis (excessive sweating).","volume":"344","author":"Heckmann","year":"2001","journal-title":"N Engl J Med"},{"issue":"7313","key":"R6-2-20210206","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/bmj.323.7313.596","article-title":"Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.","volume":"323","author":"Naumann","year":"2001","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"R8-2-20210206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/mda.2001.25138","article-title":"Botulinum toxin type A: history and current cosmetic use in the upper face.","volume":"48","author":"Carruthers","year":"2002","journal-title":"Dis Mon"},{"issue":"1","key":"R9-2-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0317167100026159","article-title":"Botulinum toxin for benign essential blepharospasm, hemifacial spasm, and age related lower eye lid entropion.","volume":"14","author":"Carruthers","year":"1987","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"R10-2-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/mda.2001.25136","article-title":"Other noncosmetic uses of Botox.","volume":"48","author":"Verheyden","year":"2002","journal-title":"Dis Mon"},{"issue":"2","key":"R11-2-20210206","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IOP.0b013e318201d1d3","article-title":"Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.","volume":"27","author":"Wojno","year":"2011","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"5","key":"R14-2-20210206","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/mda.2001.25964","article-title":"Complications and adverse reactions with the use of botulinum toxin.","volume":"48","author":"Klein","year":"2002","journal-title":"Dis Mon"},{"issue":"4","key":"R15-2-20210206","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870030409","article-title":"Systemic toxicity of botulinum toxin by intramuscular injection in the monkey.","volume":"3","author":"Scott","year":"1988","journal-title":"Mov Disord"},{"key":"R16-2-20210206","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","article-title":"Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.","volume":"53","author":"Cote","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"R17-2-20210206","first-page":"S135","article-title":"Adverse events reported with cosmetic use of botulinum toxin A.","volume":"10","author":"Gershon","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"R18-2-20210206","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1524-4725.2011.01930.x","article-title":"Facial blanching after cutaneous injections: cannulation of branches of the ophthalmic artery. Case series and review of the literature.","volume":"37","author":"Lin","year":"2011","journal-title":"Dermatol Surg"},{"issue":"1","key":"R20-2-20210206","first-page":"102","article-title":"Botulinum toxin for the treatment of facial flushing.","volume":"30","author":"Yuraitis","year":"2004","journal-title":"Dermatol Surg"},{"key":"R25-2-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP25.","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"R26-2-20210206","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve"},{"key":"R27-2-20210206","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0149-2918(00)83049-0","article-title":"Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review.","volume":"22","author":"Brashear","year":"2000","journal-title":"Clin Ther"},{"issue":"12","key":"R28-2-20210206","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1113\/jphysiol.2008.157438","article-title":"Do nerve terminal sprouts contribute to functional recovery from botulinum neurotoxin A?","volume":"586","author":"Ko","year":"2008","journal-title":"J Physiol"},{"issue":"2","key":"R29-2-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02444005","article-title":"Botulinum toxin in the therapy of gustatory sweating.","volume":"243","author":"SchulzeBonhage","year":"1996","journal-title":"J Neurol"},{"issue":"5102","key":"R30-2-20210206","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.2.5102.942","article-title":"The mechanism of postparotidectomy gustatory sweating (the auriculotemporal syndrome).","volume":"2","author":"Glaister","year":"1958","journal-title":"Br Med J"},{"key":"R31-2-20210206","first-page":"97","article-title":"Le syndrome du nerf auriculotemporal.","volume":"2","author":"Frey","year":"1923","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"R32-2-20210206","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/00016485709124377","article-title":"Gustatory sweating and flushing after conservative parotidectomy.","volume":"48","author":"LaageHellman","year":"1957","journal-title":"Acta Otolaryngol"},{"issue":"5","key":"R33-2-20210206","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/00016485809134766","article-title":"Gustatory sweating and flushing. Aetiological implications of response of separate sweat glands to various stimuli.","volume":"49","author":"LaageHellman","year":"1958","journal-title":"Acta OtoLaryng"},{"key":"R34-2-20210206","first-page":"447","article-title":"Le double reflexe vasodilatateur et sudoral de la face consecutive aux blessures de la loge parotidienne.","volume":"1","author":"Thomas","year":"1927","journal-title":"Rev Neurol (Paris)"},{"key":"R35-2-20210206","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10286-002-0026-x","article-title":"The role of gustatory flushing in Freys syndrome and its treatment with botulinum toxin type A.","volume":"12","author":"Tugnoli","year":"2002","journal-title":"Clin Auton Res"},{"issue":"6","key":"R36-2-20210206","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ana.410420619","article-title":"Treatment of gustatory sweating with botulinum toxin.","volume":"42","author":"Naumann","year":"1997","journal-title":"Ann Neurol"},{"issue":"9","key":"R37-2-20210206","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1017\/S0022215100138769","article-title":"Freys syndrome: treatment with botulinum toxin.","volume":"111","author":"Bjerkhoel","year":"1997","journal-title":"J Laryngol Otol"},{"issue":"6","key":"R38-2-20210206","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0194-5998(00)70008-8","article-title":"Frey syndrome treatment with botulinum toxin.","volume":"122","author":"Dulguerov","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R39-2-20210206","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/bjom.2000.0608","article-title":"Botulinum toxin in the treatment of Freys syndrome letter.","volume":"39","author":"Clark","year":"2001","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"4","key":"R40-2-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002341-200007000-00007","article-title":"Treatment of Freys syndrome (gustatory sweating) and crocodile tears (gustatory epiphora) with purified botulinum toxin.","volume":"16","author":"Hofmann","year":"2000","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"1","key":"R41-2-20210206","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.0007-1323.2001.01982.x","article-title":"Botulinum toxin A in the treatment of patients with Frey syndrome.","volume":"89","author":"Beerens","year":"2002","journal-title":"Br J Surg"},{"issue":"6","key":"R42-2-20210206","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1046\/j.1365-2230.2003.01379.x","article-title":"Successful use of Botulinum toxinA for the treatment of neck and anterior chest wall flushing.","volume":"28","author":"Sterodimas","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"R43-2-20210206","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00042728-200504000-00023","article-title":"Re: botulinum toxin for the treatment of facial flushing.","volume":"31","author":"Kranendonk","year":"2005","journal-title":"Dermatol Surg"},{"issue":"12","key":"R44-2-20210206","first-page":"1536","article-title":"Letter to the Editor re: successful use of Botulinum toxin A for the treatment of neck and anterior chest wall flushing.","volume":"32","author":"Alexandroff","year":"2006","journal-title":"Dermatol Surg"},{"issue":"4","key":"R45-2-20210206","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2133.2009.09248.x","article-title":"Botulinum toxin abolishes sweating via impaired sweat gland responsiveness to exogenous acetylcholine.","volume":"161","author":"Shibasaki","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"R46-2-20210206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1113\/jphysiol.1958.sp006011","article-title":"Bradykinin formation in human skin as a factor in heat vasodilatation.","volume":"142","author":"Fox","year":"1958","journal-title":"J Physiol (Lond)"},{"issue":"6","key":"R47-2-20210206","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1152\/jappl.1997.83.6.1785","article-title":"Nitric oxide and vasodilatation in human limbs.","volume":"83","author":"Joyner","year":"1997","journal-title":"J Appl Physiol"},{"issue":"2","key":"R48-2-20210206","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1152\/japplphysiol.00728.2004","article-title":"Acetylcholineinduced vasodilation is mediated by nitric oxide and prostaglandins in human skin.","volume":"98","author":"Kellogg","year":"2005","journal-title":"J Appl Physiol"},{"issue":"Pt3","key":"R49-2-20210206","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1113\/jphysiol.2004.080952","article-title":"Mechanisms of acetylcholinemediated vasodilatation in young and aged human skin.","volume":"563","author":"Holowatz","year":"2005","journal-title":"J Physiol"},{"issue":"1-2","key":"R50-2-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(94)90318-2","article-title":"Nitric oxide regulates peptide release from parasympathetic nerves and vascular reactivity to vasoactive intestinal polypeptide in vivo.","volume":"261","author":"Modin","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"R51-2-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005344-200201000-00002","article-title":"Factors critical to iontophoretic assessment of vascular reactivity: implications for clinical studies of endothelial function.","volume":"39","author":"Ramsay","year":"2002","journal-title":"J Cardiovasc Pharmacol"},{"key":"R53-2-20210206","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00691250","article-title":"Control of heatinduced cutaneous vasodilatation in relation to age.","volume":"57","author":"Kenney","year":"1988","journal-title":"Eur J Appl Physiol"},{"key":"R55-2-20210206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/jappl.1995.79.1.297","article-title":"Maximal skin vascular conductance in subjects aged 5-85 years.","volume":"79","author":"Martin","year":"1995","journal-title":"J Appl Physiol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1111\/dsu.12057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:07:28Z","timestamp":1620979648000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201301000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1111\/dsu.12057","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}